Advertisement

Gram-Negative Bacteria

  • Marc E. Grossman
  • Lindy P. Fox
  • Carrie Kovarik
  • Misha Rosenbach
Chapter

Abstract

Aeromonas species are gram-negative anaerobic rods found in fresh water lakes and streams. They have also been recovered from chlorinated tap water, including hospital water supplies. Aeromonas infections of freshwater traumatic wounds cause a characteristic clinical picture indistinguishable from group A streptococcal infection in normal hosts. Rapidly progressive cellulitis develops within 8–48 h after trauma with freshwater exposure, followed by suppuration and necrosis around the wound, often requiring surgical debridement. Fasciitis, myonecrosis, and osteomyelitis may develop. Aeromonas hydrophilia is the species that causes most soft tissue infections and bacteremias. Other species isolated include A. veronii subtype sobria and A. caviae.

Keywords

Acquire Immune Deficiency Syndrome Soft Tissue Infection Necrotizing Fasciitis Immunocompromised Host Subcutaneous Nodule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

Aeromonas

  1. 1.
    Ko WC, Chuang YC. Aeromonas bacteremia: review of 59 episodes. Clin Infect Dis. 1995;20(5):1298–304.PubMedCrossRefGoogle Scholar
  2. 2.
    Francis YF, Richman S, Hussain S, Schwartz J. Aeromonas hydrophila infection: ecthyma gangrenosum with aplastic anemia. N Y State J Med. 1982;82(10):1461–4.PubMedGoogle Scholar
  3. 3.
    Wolff RL, Wiseman SL, Kitchens CS. Aeromonas hydrophila bacteremia in ambulatory immunocompromised hosts. Am J Med. 1980;68(2):238–42.PubMedCrossRefGoogle Scholar
  4. 4.
    Cui H, Hao S, Arous E. A distinct cause of necrotizing fasciitis: Aeromonas veronii biovar sobria. Surg Infect (Larchmt). 2007;8(5):523–8.CrossRefGoogle Scholar

Bartonella

  1. 5.
    Maguiña C, Guerra H, Ventosilla P. Bartonellosis. Clin Dermatol. 2009;27(3):271–80.PubMedCrossRefGoogle Scholar
  2. 6.
    Stoler MH, Bonfiglio TA, Steigbigel RT, Pereira M. An atypical subcutaneous infection associated with acquired immune deficiency syndrome. Am J Clin Pathol. 1983;80(5):714–8.PubMedGoogle Scholar
  3. 7.
    Cockerell CJ, Whitlow MA, Webster GF, Friedman-Kien AE. Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet. 1987;2(8560):654–6.PubMedCrossRefGoogle Scholar
  4. 8.
    LeBoit PH, Berger TG, Egbert BM, et al. Epithelioid haemangioma-like vascular proliferation in AIDS manifestation of cat scratch disease bacillus infection. Lancet. 1988;1(8592):960–3.PubMedCrossRefGoogle Scholar
  5. 9.
    Knobler EH, Silvers DN, Fine KC, Lefkowitch JH, Grossman ME. Unique vascular skin lesions associated with human immunodeficiency virus. JAMA. 1988;260(4):524–7.PubMedCrossRefGoogle Scholar
  6. 10.
    Petersen K, Earhart KC, Wallace MR. Bacillary angiomatosis in a patient with chronic lymphocytic leukemia. Infection. 2008;36:480–4.PubMedCrossRefGoogle Scholar
  7. 11.
    Whitfeld MJ, Kaveh S, Koehler JE, Mead P, Berger TG. Bacillary angiomatosis associated with myositis in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1997;24(4):562–4.PubMedCrossRefGoogle Scholar
  8. 12.
    Husain S, Singh N. Pyomyositis associated with bacillary angiomatosis in a patient with HIV infection. Infection. 2002;30:50–3.PubMedCrossRefGoogle Scholar
  9. 13.
    Chian CA, Arrese JE, Piérard GE. Skin manifestations of Bartonella infections. Int J Dermatol. 2002;41(8):461–6.PubMedCrossRefGoogle Scholar
  10. 14.
    Spach DH. Bacillary angiomatosis. Int J Dermatol. 1992;31(1):19–24.PubMedCrossRefGoogle Scholar
  11. 15.
    Manders SM. Bacillary angiomatosis. Clin Dermatol. 1996;14:295–9.PubMedCrossRefGoogle Scholar
  12. 16.
    Fagan WA, DeCamp NC, Kraus EW, Pulitzer DR. Widespread cutaneous bacillary angiomatosis and a large fungating mass in an HIV-positive man. J Am Acad Dermatol. 1996;35:285–7.PubMedCrossRefGoogle Scholar
  13. 17.
    Kiss A, Moodley M, Sheldon J, Tun M. Misdiagnosed bacillary angiomatosis. S Afr Med J. 2007;97:1050.PubMedGoogle Scholar
  14. 18.
    Edmonson BC, Morris WR, Osborn FD. Bacillary angiomatosis with cytomegaloviral and mycobacterial infections of the palpebral conjunctiva in a patient with AIDS. Ophthal Plast Reconstr Surg. 2004;20(2):168–70.PubMedCrossRefGoogle Scholar
  15. 19.
    Tsai PS, DeAngelis DD, Spencer WH, Seiff SR. Bacillary angiomatosis of the anterior orbit, eyelid and conjunctiva. Am J Ophthal. 2002;134:433–5.PubMedCrossRefGoogle Scholar
  16. 20.
    Vickery CL, Dempewolf S, Porubsky ES, Faulk CT. Bacillary angiomatosis presenting as a nasal mass epistaxis. Otolaryngol Head Neck Surg. 1996;114:443–6.PubMedCrossRefGoogle Scholar
  17. 21.
    Chang AD, Drachenberg CI, James SP. Bacillary angiomatosis associated with extensive esophageal polyposis: a new mucocutaneous manifestation of acquired immunodeficiency disease (AIDS). Am J Gastroenterol. 1996;91(10):2220–3.PubMedGoogle Scholar
  18. 22.
    López de Blanc S, Sambuelli R, Femopase F, et al. Bacillary angiomatosis affecting the oral cavity. Report of two cases and review. J Oral Pathol Med. 2000;29(2):91–6.PubMedCrossRefGoogle Scholar
  19. 23.
    Julian RS, Dierks EJ, McMunn III W. Fungating mass of the anterior maxilla. J Oral Maxillofac Surg. 1999;57:1449–54.PubMedCrossRefGoogle Scholar
  20. 24.
    Karem KL, Paddock CD, Regnery RL. Bartonella henselae, B. quintana, and B. bacilliformis: historical pathogens of emerging significance. Microbes Infect. 2000;2(10):1193–205.PubMedCrossRefGoogle Scholar
  21. 25.
    Bruckert F, de Kerviler E, Zagdanski AM, et al. Sternal abscess due to Bartonella (Rochalimaea) henselae in a renal transplant patient. Skeletal Radiol. 1997;26(7):431–3.PubMedCrossRefGoogle Scholar
  22. 26.
    Bonatti H, Mendez J, Guerrero I, et al. Disseminated Bartonella infection following liver transplantation. Transplant Int. 2006;19(8):683–7.CrossRefGoogle Scholar
  23. 27.
    Koehler JE, Sanchez MA, Garrido CS, et al. Molecular epidemiology of Bartonella infection sin patients with bacillary angimatosis-peliosis. N Engl J Med. 1997;337(26):1876–83.PubMedCrossRefGoogle Scholar

Chromobacterium violaceum

  1. 28.
    Brown KL, Stein A, Morrell DS. Ecthyma gangrenosum and septic shock syndrome secondary to Chromobacterium violaceum. J Am Acad Dermatol. 2006;54(5 Suppl):S224–8.PubMedCrossRefGoogle Scholar

Citrobacter

  1. 29.
    Kluger N, Cartron G, Bessis D, Guillot B, Girard C. Citrobacter ­koseri cellulitis during anti-CD20 monoclonal antibody (ofatumumab) treatment for B-cell chronic lymphocytic leukaemia. Acta Derm Venereol. 2010;90(1):99–100.PubMedCrossRefGoogle Scholar
  2. 30.
    Gupta R, Rauf SJ, Singh S, Smith J, Agraharkar ML. Sepsis in a renal transplant recipient due to Citrobacter braakii. South Med J. 2003;96(8):796–8.PubMedCrossRefGoogle Scholar
  3. 31.
    Bishara J, Gabay B, Samra Z, Hodak E, Pitlik S. Cellulitis caused by Citrobacter diversus in a patient with multiple myeloma. Cutis. 1998;61(3):158–9.PubMedGoogle Scholar
  4. 32.
    Reich HL, Williams Fadeyi D, Naik NS, Honig PJ, Yan AC. Nonpseudomonal ecthyma gangrenosum. J Am Acad Dermatol. 2004;50(5 Suppl):S114–7.PubMedCrossRefGoogle Scholar
  5. 33.
    Schlossberg D, Ricci JA, Fugate JS. Dermatologic manifestations of citrobacter septicemia. J Am Acad Dermatol. 1981;5(5):613–5.PubMedCrossRefGoogle Scholar
  6. 34.
    Grant MD, Horowitz HI, Lorian V. Gangrenous ulcer and septicemia due to citrobacter. N Engl J Med. 1969;280(23):1286–7.PubMedCrossRefGoogle Scholar

Enterobacter

  1. 35.
    Livingston W, Grossman ME, Garvey G. Hemorrhagic bullae in association with Enterobacter cloacae septicemia. J Am Acad Dermatol. 1992;27:637–8.PubMedCrossRefGoogle Scholar

Escherichia coli

  1. 36.
    Patel JK, Perez OA, Viera MH, Halem M, Berman B. Ecthyma gangrenosum caused by Escherichia coli bacteremia: a case report and review of the literature. Cutis. 2009;84(5):261–7.PubMedGoogle Scholar
  2. 37.
    Fisher K, Berger BW, Keusch GT. Subepidermal bullae secondary to Escherichia coli septicemia. Arch Dermatol. 1974;110(1):105–6.PubMedCrossRefGoogle Scholar
  3. 38.
    Hansen EA, Cunha BA. Escherichia coli chest-wall hemorrhagic cellulitis associated with central-line placement. Heart Lung. 2000;29(6):450–2.PubMedCrossRefGoogle Scholar
  4. 39.
    Chapman RA, Van Slyck EJ, Madhavan T. Skin lesions associated with E. coli sepsis in a patient with acute leukemia. Henry Ford Hosp Med J. 1980;28(1):47–8.PubMedGoogle Scholar
  5. 40.
    Castanet J, Lacour JP, Perrin C, et al. Escherichia coli cellulitis: two cases. Acta Derm Venereol. 1992;72(4):310–1.PubMedGoogle Scholar
  6. 41.
    Yoon TY, Jung SK, Chang SH. Cellulitis due to Escherichia coli in three immunocompromised subjects. Br J Dermatol. 1998;139(5):885–8.PubMedCrossRefGoogle Scholar
  7. 42.
    Brzozowski D, Ross DC. Upper limb Escherichia coli cellulitis in the immunocompromised. J Hand Surg Br. 1997;22(5):679–80.PubMedCrossRefGoogle Scholar
  8. 43.
    Dreizen S, McCredie KB, Bodey GP, Keating MJ. Unusual mucocutaneous infections in immunosuppressed patients with leukemia–expansion of an earlier study. Postgrad Med. 1986;79(4):287–94.PubMedGoogle Scholar
  9. 44.
    Paterson DL, Gruttadauria S, Lauro A, Scott V, Marino IR. Spontaneous gram-negative cellulitis in a liver transplant recipient. Infection. 2001;29(6):345–7.PubMedCrossRefGoogle Scholar
  10. 45.
    Barnard M, Chalvardjian A. Cutaneous malakoplakia in a patient with acquired immunodeficiency syndrome (AIDS). Am J Dermato­pathol. 1998;20(2):185–8.PubMedCrossRefGoogle Scholar
  11. 46.
    Wittenberg PG, Douglass MC, Azam M, et al. Cutaneous malacoplakia in a patient with the acquired immunodeficiency syndrome. Arch Dermatol. 1998;134(2):244–5.PubMedCrossRefGoogle Scholar
  12. 47.
    Palou J, Torras H, Baradad M, et al. Cutaneous malakoplakia. Report of a case. Dermatologica. 1988;176(6):288–92.PubMedCrossRefGoogle Scholar

Helicobacter cinaedi

  1. 48.
    Minauchi K, Takahashi S, Sakai T, et al. The nosocomial transmission of Helicobacter cinaedi infections in immunocompromised patients. Intern Med. 2010;49(16):1733–9. Epub 2010 Aug 13.PubMedCrossRefGoogle Scholar
  2. 49.
    Uçkay I, Garbino J, Dietrich PY, et al. Recurrent bacteremia with Helicobacter cinaedi: case report and review of the literature. BMC Infect Dis. 2006;6:86.PubMedCrossRefGoogle Scholar
  3. 50.
    Simons E, Spacek LA, Lederman HM, Winkelstein JA. Helicobacter cinaedi bacteremia presenting as macules in an afebrile patient with X-linked agammaglobulinemia. Infection. 2004;32(6):367–8.PubMedCrossRefGoogle Scholar
  4. 51.
    Sullivan AK, Nelson MR, Walsh J, Gazzard BG. Recurrent Helicobacter cinaedi cellulitis and bacteraemia in a patient with HIV Infection. Int J STD AIDS. 1997;8(1):59–60.PubMedCrossRefGoogle Scholar
  5. 52.
    Kiehlbauch JA, Tauxe RV, Baker CN, Wachsmuth IK. Evaluation of ribotyping techniques as applied to Arcobacter, Campylobacter and Helicobacter. Mol Cell Probes. 1994;8(2):109–15.PubMedCrossRefGoogle Scholar
  6. 53.
    Burman WJ, Cohn DL, Reves RR, Wilson ML. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis. 1995;20(3):564–70.PubMedCrossRefGoogle Scholar
  7. 54.
    van der Ven AJ, Kullberg BJ, Vandamme P, Meis JF. Helicobacter cinaedi bacteremia associated with localized pain but not with cellulitis. Clin Infect Dis. 1996;22(4):710–1.PubMedCrossRefGoogle Scholar

Klebsiella

  1. 55.
    Ashour HM, El-Sharif A. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents. Arch Pharm (Weinheim). 2009;342(5):299–310.CrossRefGoogle Scholar
  2. 56.
    Rodot S, Lacour JP, van Elslande L, et al. Ecthyma gangrenosum caused by Klebsiella pneumoniae. Int J Dermatol. 1995;34(3):216–7.PubMedCrossRefGoogle Scholar
  3. 57.
    Gunnarsson GL, Brandt PB, Gad D, Struve C, Justesen US. Monomicrobial necrotizing fasciitis in a white male caused by hypermucoviscous Klebsiella pneumoniae. J Med Microbiol. 2009;58(Pt 11):1519–21.PubMedCrossRefGoogle Scholar
  4. 58.
    DiGioia RA, Kane JG, Parker RH. Crepitant cellulitis and myonecrosis caused by Klebsiella. JAMA. 1977;237(19):2097–8.PubMedCrossRefGoogle Scholar
  5. 59.
    Napgezek MR, Hall WH. Nonclostridial crepitant cellulitis due to Klebsiella. Minn Med. 1975;58(5):377–8.PubMedGoogle Scholar
  6. 60.
    Fragoulis KN, Klouvas GD, Falagas ME. Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae. Am J Med. 2005;118(8):925–7.PubMedCrossRefGoogle Scholar
  7. 61.
    Erbagci Z. Noma-like gangrenous cheilitis in a child with cyclic neutropenia associated with myeloperoxidase deficiency. Pediatr Dermatol. 2003;20(6):519–23.PubMedCrossRefGoogle Scholar

Legionella

  1. 62.
    Waldor MK, Wilson B, Swartz M. Cellulitis caused by Legionella pneumophila. Clin Infect Dis. 1993;16(1):51–3.PubMedCrossRefGoogle Scholar
  2. 63.
    Han JH, Nguyen JC, Harada S, Baddour LM, Edelstein PH. Relapsing Legionella pneumophila cellulitis: a case report and review of the literature. J Infect Chemother. 2010;16(6):439–42.PubMedCrossRefGoogle Scholar
  3. 64.
    Ampel NM, Ruben FL, Norden CW. Cutaneous abscess caused by Legionella micdadei in an immunosuppressed patient. Ann Intern Med. 1985;102(5):630–2.PubMedGoogle Scholar
  4. 65.
    Kilborn JA, Manz LA, O’Brien M, et al. Necrotizing cellulitis caused by Legionella micdadei. Am J Med. 1992;92(l):104–6.PubMedCrossRefGoogle Scholar
  5. 66.
    Chee CE, Baddour LM. Legionella maceachernii soft tissue infection. Am J Med Sci. 2007;334(5):410–3.PubMedCrossRefGoogle Scholar
  6. 67.
    Gubler JG, Schorr M, Gaia V, Zbinden R, Altwegg M. Recurrent soft tissue abscesses caused by Legionella cincinnatiensis. J Clin Microbiol. 2001;39(12):4568–70.PubMedCrossRefGoogle Scholar
  7. 68.
    Loridant S, Lagier JC, La Scola B. Identification of Legionella feeleii cellulitis. Emerg Infect Dis. 2011;17(1):145–6.PubMedCrossRefGoogle Scholar

Morganella

  1. 69.
    Arranz-Caso JA, Cuadrado-Gomez LM, Romanik-Cabrera J, García-Tena J. Pyomyositis caused by Morganella morganii in a patient with AIDS. Clin Infect Dis. 1996;22(2):372–3.PubMedCrossRefGoogle Scholar
  2. 70.
    Bagel J, Grossman ME. Hemorrhagic bullae associated with Morganella morganii septicemia. J Am Acad Dermatol. 1985;12(3):575–6.PubMedCrossRefGoogle Scholar
  3. 71.
    Ghosh S, Bal AM, Malik I, Collier A. Fatal Morganella morganii bacteraemia in a diabetic patient with gas gangrene. J Med Microbiol. 2009;58(Pt 7):965–7.PubMedCrossRefGoogle Scholar
  4. 72.
    Lobo I, Pinto A, Ferreira M, et al. Non-pseudomonal ecthyma gangrenosum present in diclofenac-induced agranulocytosis. Eur J Dermatol. 2008;18(3):350–1.PubMedGoogle Scholar

Pseudomonas

  1. 73.
    Roberts R, Tarpay MM, Marks MI, Nitschke R. Erysipelas-like lesions and hyperesthesia as manifestations of Pseudomonas aeruginosa sepsis. JAMA. 1982;248(17):2156–7.PubMedCrossRefGoogle Scholar
  2. 74.
    Song WK, Kim YC, Park HJ, Cinn YW. Ecthyma gangrenosum without bacteraemia in a leukaemic patient. Clin Exp Dermatol. 2001;26(5):395–7.PubMedCrossRefGoogle Scholar
  3. 75.
    Collini FJ, Spees EK, Munster A, Dufresne C, Millan J. Ecthyma gangrenosum in a kidney transplant recipient with Pseudomonas septicemia. Am J Med. 1986;80(4):729–34.PubMedCrossRefGoogle Scholar
  4. 76.
    Huminer D, Siegman-lgra Y, Morduchowicz G, Pitlik SD. Ecthyma gangrenosum without bacteremia. Report of six cases and review of the literature. Arch Intern Med. 1987;147(2):299–301.PubMedCrossRefGoogle Scholar
  5. 77.
    Blumenthal NC, Sood UR, Aronson PJ, Hashimoto K. Facial liberations in an immunocompromised patient. Ecthyma gangrenosum. Arch Dermatol. 1990;126(4):529–32.PubMedCrossRefGoogle Scholar
  6. 78.
    Singh N, Devi M, Devi S. Ecthyma gangrenosum: a rare cutaneous manifestation caused by Pseudomonas aeruginosa without bacteremia in a leukemic patient. Indian J Dermatol Venereol Leprol. 2005;71(2):128–9.PubMedCrossRefGoogle Scholar
  7. 79.
    Kusne S, Eibling DE, Yu VL, et al. Gangrenous cellulitis associated with gram-negative bacilli in pancytopenic patients: dilemma with respect to effective therapy. Am J Med. 1988;85(4):490–4.PubMedCrossRefGoogle Scholar
  8. 80.
    Falagas ME, Pappas VD, Michalopoulos A. Gangrenous, hemorrhagic, bullous cellulitis associated with Pseudomonas aeruginosa in a patient with Waldenstrom’s macroglobulinemia. Infection. 2007;35(5):370–3.PubMedCrossRefGoogle Scholar
  9. 81.
    Koriech OM, Al-Dash FZ. Skin and bone necrosis following ecthyma gangrenosum in acute leukaemia-report of three cases. Clin Exp Dermatol. 1988;13(2):78–81.PubMedCrossRefGoogle Scholar
  10. 82.
    Bourelly PE, Grossman ME. Subcutaneous nodule as a manifestation of Pseudomonas sepsis in an immunocompromised host. Clin Infect Dis. 1998;26(1):188–9.PubMedCrossRefGoogle Scholar
  11. 83.
    Bagel J, Grossman ME. Subcutaneous nodules in Pseudomonas sepsis. Am J Med. 1986;80(3):528–9.PubMedCrossRefGoogle Scholar
  12. 84.
    Berger TG, Kaveh S, Becker D, Hoffman J. Cutaneous manifestations of Pseudomonas infections in AIDS. J Am Acad Dermatol. 1995;32(2 Pt 1):279–80.PubMedCrossRefGoogle Scholar
  13. 85.
    Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis. 1992;14(2):403–11.PubMedCrossRefGoogle Scholar

Salmonella

  1. 86.
    Dhanoa A, Fatt QK. Non-typhoidal Salmonella bacteraemia: epidemiology, clinical characteristics and its’ association with severe immunosuppression. Ann Clin Microbiol Antimicrob. 2009;8:15.PubMedCrossRefGoogle Scholar
  2. 87.
    Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32(2):263–9.PubMedCrossRefGoogle Scholar
  3. 88.
    Gordon MA. Salmonella infections in immunocompromised adults. J Infect. 2008;56(6):413–22.PubMedCrossRefGoogle Scholar
  4. 89.
    Hames A, Mumford J, Hale J, Galloway A. Salmonella Michigan soft tissue infection in an immunocompromised child. J Clin Pathol. 2008;61(6):773–4.PubMedCrossRefGoogle Scholar
  5. 90.
    Andriessen MJ, Kotsopoulos AM, Bloemers FW, Strack Van Schijndel RJ, Girbes AR. Necrotizing fasciitis caused by Salmonella enteritidis. Scand J Infect Dis. 2006;38(11–12):1106–7.PubMedCrossRefGoogle Scholar
  6. 91.
    Rosser A, Swallow G, Swann RA, Chapman C. Salmonella enteritidis necrotising fasciitis in a multiple myeloma patient receiving bortezomib. Int J Hematol. 2010;91(1):149–51.PubMedCrossRefGoogle Scholar
  7. 92.
    Shamiss A, Thaler M, Nussinovitch N, Zissin R, Rosenthal T. Multiple Salmonella enteritidis leg abscesses in a patient with systemic lupus erythematosus. Postgrad Med J. 1990;66(776):486–8.PubMedCrossRefGoogle Scholar
  8. 93.
    Wolinsky S, Grossman ME, Walther RR, Silvers DN, Neu HC. Hemorrhagic bullae associated with salmonella septicemia. N Y State J Med. 1981;81(11):1639–41.PubMedGoogle Scholar

Serratia

  1. 94.
    Bonner MJ, Meharg Jr JG. Primary cellulitis due to Serratia marcescens. JAMA. 1983;250(17):2348–9.PubMedCrossRefGoogle Scholar
  2. 95.
    Huang JW, Fang CT, Hung KY, et al. Necrotizing fasciitis caused by Serratia marcescens in two patients receiving corticosteroid therapy. J Formos Med Assoc. 1999;98(12):851–4.PubMedGoogle Scholar
  3. 96.
    Bachmeyer C, Sanguina M, Turc Y, Reynaert G, Blum L. Necrotizing fasciitis due to Serratia marcescens. Clin Exp Dermatol. 2004;29(6):673–4.PubMedCrossRefGoogle Scholar
  4. 97.
    Langrock ML, Linde HJ, Landthaler M, Karrer S. Leg ulcers and abscesses caused by Serratia marcescens. Eur J Dermatol. 2008;18(6):705–7.PubMedGoogle Scholar
  5. 98.
    Friend JC, Hilligoss DM, Marguesen M, et al. Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease. J Allergy Clin Immunol. 2009;124(1):164–6.PubMedCrossRefGoogle Scholar
  6. 99.
    Hartmann F, Gheorghiu T, Leupold H, Baer F, Diehl V. Serratia infections in patients with neutropenia. Klin Wochenschr. 1991;69(11):491–4.PubMedCrossRefGoogle Scholar
  7. 100.
    Gössl M, Eggebrecht H. Necrotizing skin ulceration in antibiotic-induced agranulocytosis. Mayo Clin Proc. 2006;81(12):1527.PubMedCrossRefGoogle Scholar
  8. 101.
    Muñoz-Pérez MA, Rodriguez-Pichardo A, Camacho F. Disseminated papular eruption caused by Serratia marcescens: a new cutaneous manifestation in HIV-positive patients. AIDS. 1996;10(10):1179–80.PubMedGoogle Scholar

Stenotrophomonas

  1. 102.
    Sakhnini E, Weissmann A, Oren I. Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an out­break transmitted via tap water. Am J Med Sci. 2002;323(5):269–72.PubMedCrossRefGoogle Scholar
  2. 103.
    Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis. 2007;45(12):1602–9.PubMedCrossRefGoogle Scholar
  3. 104.
    Teo WY, Chan MY, Lam CM, Chong CY. Skin manifestation of Stenotrophomonas maltophilia infection—a case report and review article. Ann Acad Med Singapore. 2006;35(12):897–900.PubMedGoogle Scholar
  4. 105.
    Moser C, Jønsson V, Thomsen K, et al. Subcutaneous lesions and bacteraemia due to Stenotrophomonas maltophilia in three leukaemic patients with neutropenia. Br J Dermatol. 1997;136(6):949–52.PubMedCrossRefGoogle Scholar
  5. 106.
    Smeets JG, Lowe SH, Veraart JC. Cutaneous infections with Stenotrophomonas maltophilia in patients using immunosuppressive medication. J Eur Acad Dermatol Venereol. 2007;21(9):1298–300.PubMedGoogle Scholar
  6. 107.
    Burns RL, Lowe L. Xanthomonas maltophilia infection presenting as erythematous nodules. J Am Acad Dermatol. 1997;37(5 Pt 2):836–8.PubMedCrossRefGoogle Scholar
  7. 108.
    Sefcick A, Tait RC, Wood B. Stenotrophomonas maltophilia: an increasing problem in patients with acute leukaemia. Leuk Lymphoma. 1999;35(1–2):207–11.PubMedCrossRefGoogle Scholar
  8. 109.
    Vartivarian SE, Papadakis KA, Palacios JA, Manning Jr JT, Anaissie EJ. Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum. Ann Intern Med. 1994;121(12):969–73.PubMedGoogle Scholar
  9. 110.
    Bin Abdulhak AA, Zimmerman V, Al Beirouti BT, Baddour LM, Tleyjeh IM. Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature. Diagn Microbiol Infect Dis. 2009;63(3):330–3.PubMedCrossRefGoogle Scholar
  10. 111.
    Son YM, Na SY, Lee HY, Baek JO, Lee JR, Roh JY. Ecthyma gangrenosum: a rare cutaneous manifestation caused by Stenotro­phomonas maltophilia in a leukemic patient. Ann Dermatol. 2009;21(4):389–92.PubMedCrossRefGoogle Scholar
  11. 112.
    Muder RR, Yu VL, Dummer JS, Vinson C, Lumish RM. Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med. 1987;147(9):1672–4.PubMedCrossRefGoogle Scholar
  12. 113.
    Pham BN, Aractingi S, Dombret H, et al. Xanthomonas (formerly Pseudomonas) maltophilia-induced cellulitis in a neutropenic patient. Arch Dermatol. 1992;128(5):702–4.PubMedCrossRefGoogle Scholar

Vibrio

  1. 114.
    Payinda G. Necrotizing fasciitis due to Vibrio parahaemolyticus. N Z Med J. 2008;121(1283):99–101.PubMedGoogle Scholar
  2. 115.
    Farina C, Luzzi I, Lorenzi N. Vibrio cholerae 02 sepsis in a patient with AIDS. Eur J Clin Microbiol Infect Dis. 1999;18(3):203–5.PubMedCrossRefGoogle Scholar
  3. 116.
    Thodis E, Kriki P, Kakagia D, et al. Rigorous Vibrio vulnificus soft tissue infection of the lower leg in a renal transplant patient managed by vacuum therapy and autologous growth factors. J Cutan Med Surg. 2009;13(4):209–14.PubMedGoogle Scholar
  4. 117.
    Kuhnt-Lenz K, Krengel S, Fetscher S, Heer-Sonderhoff A, Solbach W. Sepsis with bullous necrotizing skin lesions due to vibrio vulnificus acquired through recreational activities in the Baltic Sea. Eur J Clin Microbiol Infect Dis. 2004;23(l):49–52.PubMedGoogle Scholar
  5. 118.
    Lee CC, Tong KL, Howe HS, Lam MS. Vibrio vulnificus infections: case reports and literature review. Ann Acad Med Singapore. 1997;26(5):705–12.PubMedGoogle Scholar
  6. 119.
    Iwata Y, Sato S, Murase Y, et al. Five cases of necrotizing fasciitis: lack of skin inflammatory signs as a clinical clue for the fulminant type. J Dermatol. 2008;35(11):719–25.PubMedCrossRefGoogle Scholar
  7. 120.
    Nakafusa J, Misago N, Miura Y, et al. The importance of serum creatine phosphokinase level in the early diagnosis, and as a prognostic factor, of Vibrio vulnificus infection. Br J Dermatol. 2001;145(2):280–4.PubMedCrossRefGoogle Scholar
  8. 121.
    Kuo Chou TN, Chao WN, Yang C, et al. Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus. World J Surg. 2010;34(7):1669–75.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Marc E. Grossman
    • 1
  • Lindy P. Fox
    • 2
  • Carrie Kovarik
    • 3
  • Misha Rosenbach
    • 4
  1. 1.New York Presbyterian HospitalColumbia University Medical CenterNew YorkUSA
  2. 2.University of California, San FranciscoSan FranciscoUSA
  3. 3.Dermatopathology, and Infectious DiseasesUniversity of PennsylvaniaPhiladelphiaUSA
  4. 4.University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations